These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21668996)

  • 1. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.
    Chen Y; Xu J; Borowicz S; Collins C; Huo D; Olopade OI
    BMC Cancer; 2011 Jun; 11():246. PubMed ID: 21668996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 activation of the GADD45 promoter.
    Jin S; Zhao H; Fan F; Blanck P; Fan W; Colchagie AB; Fornace AJ; Zhan Q
    Oncogene; 2000 Aug; 19(35):4050-7. PubMed ID: 10962562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
    Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI
    Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma.
    Yang F; Xue X; Bi J; Zheng L; Zhi K; Gu Y; Fang G
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):437-45. PubMed ID: 23143645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element.
    Atlas E; Stramwasser M; Mueller CR
    Oncogene; 2001 Oct; 20(48):7110-4. PubMed ID: 11704836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a negative transcriptional element in the BRCA1 promoter.
    MacDonald G; Stramwasser M; Mueller CR
    Breast Cancer Res; 2007; 9(4):R49. PubMed ID: 17663789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer.
    Gorski JJ; James CR; Quinn JE; Stewart GE; Staunton KC; Buckley NE; McDyer FA; Kennedy RD; Wilson RH; Mullan PB; Harkin DP
    Breast Cancer Res Treat; 2010 Aug; 122(3):721-31. PubMed ID: 19882246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
    Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
    Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
    Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
    Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells.
    Zhou C; Liu J
    Biochem Biophys Res Commun; 2003 Mar; 303(1):130-6. PubMed ID: 12646176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 interaction with human papillomavirus oncoproteins.
    Zhang Y; Fan S; Meng Q; Ma Y; Katiyar P; Schlegel R; Rosen EM
    J Biol Chem; 2005 Sep; 280(39):33165-77. PubMed ID: 15983032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
    Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
    Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
    Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer.
    Ma MZ; Li CX; Zhang Y; Weng MZ; Zhang MD; Qin YY; Gong W; Quan ZW
    Mol Cancer; 2014 Jun; 13():156. PubMed ID: 24953832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
    Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Dadmanesh F; Koeffler HP
    Oncogene; 2002 May; 21(20):3199-206. PubMed ID: 12082635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive regulation of the BRCA1 promoter.
    Thakur S; Croce CM
    J Biol Chem; 1999 Mar; 274(13):8837-43. PubMed ID: 10085126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
    Hockings JK; Degner SC; Morgan SS; Kemp MQ; Romagnolo DF
    Breast Cancer Res; 2008; 10(2):R29. PubMed ID: 18377656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression.
    Deng G; Chen A; Pong E; Kim YS
    Oncogene; 2001 Oct; 20(48):7120-7. PubMed ID: 11704838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.